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Candida Albicans Stimulates Streptococcus Mutans Microcolony
Development via Cross-Kingdom Biofilm-Derived Metabolites
Abstract
Candida albicans is frequently detected with heavy infection of Streptococcus mutans in plaque-biofilms from
children affected with early-childhood caries, a prevalent and costly oral disease. The presence of C. albicans
enhances S. mutans growth within biofilms, yet the chemical interactions associated with bacterial
accumulation remain unclear. Thus, this study was conducted to investigate how microbial products from this
cross-kingdom association modulate S. mutans build-up in biofilms. Our data revealed that bacterial-fungal
derived conditioned medium (BF-CM) significantly increased the growth of S. mutans and altered biofilm
3D-architecture in a dose-dependent manner, resulting in enlarged and densely packed bacterial cell-clusters
(microcolonies). Intriguingly, BF-CM induced S. mutans gtfBC expression (responsible for Gtf exoenzymes
production), enhancing Gtf activity essential for microcolony development. Using a recently developed
nanoculture system, the data demonstrated simultaneous microcolony growth and gtfB activation in situ by
BF-CM. Further metabolites/chromatographic analyses of BF-CM revealed elevated amounts of formate and
the presence of Candida-derived farnesol, which is commonly known to exhibit antibacterial activity.
Unexpectedly, at the levels detected (25–50 μM), farnesol enhanced S. mutans-biofilm cell growth,
microcolony development, and Gtf activity akin to BF-CM bioactivity. Altogether, the data provide new
insights on how extracellular microbial products from cross-kingdom interactions stimulate the accumulation
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Candida albicans stimulates 
Streptococcus mutans microcolony 
development via cross-kingdom 
biofilm-derived metabolites
Dongyeop Kim1, Arjun Sengupta2, Tagbo H. R. Niepa3, Byung-Hoo Lee4, Aalim Weljie2, 
Veronica S. Freitas-Blanco5, Ramiro M. Murata5, Kathleen J. Stebe3, Daeyeon Lee3 & 
Hyun Koo1
Candida albicans is frequently detected with heavy infection of Streptococcus mutans in plaque-biofilms 
from children affected with early-childhood caries, a prevalent and costly oral disease. The presence of 
C. albicans enhances S. mutans growth within biofilms, yet the chemical interactions associated with 
bacterial accumulation remain unclear. Thus, this study was conducted to investigate how microbial 
products from this cross-kingdom association modulate S. mutans build-up in biofilms. Our data 
revealed that bacterial-fungal derived conditioned medium (BF-CM) significantly increased the growth 
of S. mutans and altered biofilm 3D-architecture in a dose-dependent manner, resulting in enlarged 
and densely packed bacterial cell-clusters (microcolonies). Intriguingly, BF-CM induced S. mutans 
gtfBC expression (responsible for Gtf exoenzymes production), enhancing Gtf activity essential for 
microcolony development. Using a recently developed nanoculture system, the data demonstrated 
simultaneous microcolony growth and gtfB activation in situ by BF-CM. Further metabolites/
chromatographic analyses of BF-CM revealed elevated amounts of formate and the presence of 
Candida-derived farnesol, which is commonly known to exhibit antibacterial activity. Unexpectedly, 
at the levels detected (25–50 μM), farnesol enhanced S. mutans-biofilm cell growth, microcolony 
development, and Gtf activity akin to BF-CM bioactivity. Altogether, the data provide new insights on 
how extracellular microbial products from cross-kingdom interactions stimulate the accumulation of a 
bacterial pathogen within biofilms.
Early childhood caries (ECC) is a highly prevalent and difficult to treat biofilm-dependent oral disease, afflicting 
mostly underprivileged children worldwide, resulting in an estimated annual expenditures of > $120 billion in 
the US alone1,2. Children affected with ECC display heavy infection with Streptococcus mutans accompanied by 
protracted feeding of dietary sugars, such as sucrose3–5, leading to rapid accumulation of virulent biofilms that 
cause rampant destruction of the teeth1,6.
Caries-causing biofilms develop when bacteria interact with dietary sugars and accumulate on tooth surface, 
forming densely packed cell clusters (or microcolonies) that are firmly adherent and enmeshed in an extracellular 
matrix of polymeric substances such as exopolysaccharides (EPS)7. EPS, particularly glucans, enhance bacterial 
adhesion and cohesion, while forming a diffusion-limiting matrix that protects the embedded bacteria and helps 
to acidify the local microenvironment. These biofilm properties promote the growth of an acidogenic microbiota, 
and eventually lead to the onset of dental caries8–10.
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S. mutans is regarded as one of the key etiologic agents of ECC because this pathogen can efficiently catalyze 
dietary sucrose into extracellular glucans using several exoenzymes (glucosyltransferases or Gtfs) making it a 
primary EPS producer in the oral cavity, while being both acidogenic and acid-tolerant7. However, S. mutans 
may not act alone in cariogenic biofilms, as additional organisms may be involved6. Results from clinical studies 
reveal that C. albicans is frequently detected with high numbers of S. mutans in plaque-biofilms from children 
with ECC11–15. These findings are intriguing, because this opportunistic fungus usually neither binds well with 
S. mutans, nor colonizes teeth effectively on its own16–18. Rather, C. albicans interacts with commensal (viridans) 
streptococci and form biofilms on acrylic/mucosal surfaces19,20 to cause oral mucosal infections21,22. However, 
physical coadhesion of S. mutans and C. albicans is drastically enhanced in the presence of sucrose; these condi-
tions also promote biofilm formation17,23–25.
Further in vitro studies have demonstrated that S. mutans-derived Gtfs play a key role by binding avidly to the 
fungal surface in an enzymatically active form17,26. When sucrose is available, surface-bound exoenzymes produce 
large amounts of EPS on the fungal surface, which provide enhanced binding sites for S. mutans, thereby promot-
ing their adhesive interactions and crosskingdom biofilm development25. Using a rodent model of the disease, an 
enhancement of S. mutans levels in plaque-biofilms was observed when co-infected with C. albicans and exposed 
to a sucrose-rich diet25. Importantly, the virulence was significantly increased, leading to the onset of rampant 
caries on teeth similar to those found in ECC.
Associations between bacteria and fungi can be antagonistic or cooperative22,27,28. Once together within bio-
films, these organisms may cooperate with each other for provision of substrates/metabolites or growth stim-
ulating factors when conditions are conducive for ECC. For example, Candida does not metabolize sucrose 
efficiently29, and could benefit from cross-feeding of sucrose break-down products (glucose and fructose) by S. 
mutans30,31. Conversely, the presence of C. albicans dramatically modifies the physical environment of the bio-
films by increasing EPS production that is critical for S. mutans accumulation and formation of microcolonies25. 
Furthermore, C. albicans appears to activate S. mutans genes associated with EPS/fitness25 and competence 
genes31. However, the manner in which such chemical interactions and secreted molecules stimulate S. mutans 
growth and accumulation remains unclear.
Thus, this study investigates whether extracellular microbial products derived from S. mutans-C. albi-
cans biofilm interactions modulate the bacterial population build-up within biofilms. Our data revealed that 
bacterial-fungal conditioned medium (BF-CM) significantly increased the growth of S. mutans biofilm cells and 
enhanced microcolony formation through triggering of Gtfs activity via up-regulation of gtfBC. Using a recently 
developed microcapsule-based nanoculture and a S. mutans gtfB::green fluorescence protein promoter, the data 
demonstrated that BF-CM stimulated bacterial cells confined within these semipermeable chambers to develop 
into microcolonies while inducing gtfB expression in situ. Metabolite profiling and chromatographic analyses 
of BF-CM revealed elevated amounts of formate and the presence of farnesol, a quorum-sensing molecule from 
C. albicans that is commonly understood to exhibit antibacterial activity. Surprisingly, farnesol levels (25–50 μ M) 
detected in BF-CM enhanced S. mutans cell growth, microcolony development, and Gtfs activity in a manner 
similar to that observed with BF-CM. However, higher concentrations (> 100 μ M) of farnesol inhibited S. mutans 
growth. Thus, farnesol is a potential key modulator in this crosskingdom interaction, and S. mutans growth 
responds non-monotonically to farnesol concentration. Altogether, this study provides new insights on the chem-
ical interactions between an opportunistic fungus (C. albicans) and an oral pathogen (S. mutans), which could 
help explain how their association lead to virulent biofilms in ECC.
Results
Bacterial-fungal derived conditioned medium (BF-CM) promotes S. mutans growth and 
microcolony development. Conditioned medium (CM) was collected and prepared from single-species 
bacterial (S. mutans; B-CM), single-species fungal (C. albicans; F-CM) or bacterial-fungal (BF-CM) biofilms at 
three time-points (6, 18 and 30 h) corresponding to active biofilm formation using our sHA model (Figs 1A and 
S1; also Fig. S2 shows their overall architecture). Initially the influences of various CM preparations on S. mutans 
biofilm-cells growth were evaluated. The results showed that BF-CM collected at 18 h significantly promoted bac-
terial accumulation within biofilms compared to control (no supplementation, P < 0.001) (Fig. 1A). In contrast, 
no significant increase in the bacterial cell population was detected when S. mutans was grown in CM prepara-
tions from single-species biofilms or from BF-CM at other time-points. It appears that during the initial phase of 
active biofilm formation (between 6 h to 18 h) the presence of cross-kingdom metabolites could be enhancing S. 
mutans cell growth, while at the later time point (30 h) this effect is attenuated possibly due to reduced microbial/
metabolic activity. Thus, hereafter further experiments were focused on the bioactivity of BF-CM collected at 18 h 
on biofilm formation by S. mutans. Using different dilutions of BF-CM, the data showed a clear trend of increasing 
number of viable S. mutans-biofilm cells (> 6-fold increase at highest BF-CM content vs. no supplementation) in 
a dose-dependent manner (r2 = 0.9; Fig. 1B) suggesting that BF-CM contains bacterial growth-inducing factors.
Furthermore, confocal imaging revealed significant alterations in the biofilm three-dimensional (3D) archi-
tecture with enhanced bacterial clustering and accumulation when grown in the presence of increased amounts of 
BF-CM (Fig. 1C). It showed enlarged and densely packed microcolonies (in green) enmeshed in a well-developed 
EPS matrix (in red) (Fig. 2A). Quantitative computational analyses (COMSTAT) showed significantly higher 
total biomass and cell/EPS ratio in S. mutans biofilms formed in BF-CM, while the volume of the microcolony 
was increased by ~2.5 fold (vs. control, P < 0.01) (Fig. 2B). Therefore, BF-CM appears to enhance microcolony 
development with an elevated carriage of S. mutans cells.
BF-CM modulates the dynamics of S. mutans-derived glucosyltransferases (Gtfs) activity. 
Since microcolony development is linked with the activity of Gtf exoenzymes32,33, the impact of BF-CM on total 
Gtfs activity and gtf gene expression during S. mutans biofilm formation was further investigated (Fig. 3). The 
www.nature.com/scientificreports/
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biofilms were formed with varying BF-CM dilutions, and the supernatant collected for Gtfs activity as meas-
ured by scintillation counting using radiolabeled sucrose. Linear regression analysis showed that Gtfs activity 
correlated strongly with increasing amounts of extracellular microbial products in BF-CM (r2 = 0.97) (Fig. 3A). 
Also, temporal effects were examined to confirm whether the inducing effects of BF-CM on Gtfs activity were 
dependent on the stage of biofilm development. Interestingly, Gtfs activity was significantly enhanced by BF-CM 
(~2-fold increase vs. control, P < 0.01; Fig. 3B) during the early-stage of biofilm formation (18–28 h). However, 
no significant effects were observed in matured biofilms (42 h) (Fig. 3B). Hence, exposure to BF-CM can increase 
Gtfs activity during biofilm initiation, promoting S. mutans ability to form cell clusters and microcolonies onto 
sHA surface.
Furthermore, additional experiments were conducted to examine the manner in which BF-CM influences the 
pattern of gtfB and gtfC expression, which encodes the primary Gtfs associated with microcolony development 
by S. mutans33. Notably, gtfB expression was up-regulated as early as 22 h within biofilms formed with BF-CM, 
while both gtfB and gtfC were dramatically induced (~3-fold increase vs. control, P < 0.001; Fig. 3C) at 28 h of 
development. Altogether, the data reveal that BF-CM contains microbial products that are capable of both stim-
ulating bacterial growth and inducing Gtfs activity, consistent with elevated population of bacterial cells (Fig. 1) 
and development of enlarged microcolonies within biofilms formed in the presence of BF-CM (Fig. 2B).
Microcolony assembly and gtfB expression in situ using a semipermeable nanoculture sys-
tem. To further demonstrate the biological properties of BF-CM, a newly developed nanoliter-scale cultur-
ing system was used, which allows microbial growth within spatially confined yet permeable microcapsules, 
Figure 1. Influences of conditioned medium on the growth of S. mutans biofilm cells and microcolony 
development. (A) Conditioned medium (CM) was collected and prepared from single-species bacterial  
(B-CM), fungal (F-CM) or bacterial-fungal (BF-CM) biofilms at different time points. S. mutans biofilms were 
grown on saliva-coated hydroxyapatite (sHA) disc surface in each of the CM preparations (1:5 vol/vol,  
CM:UFTYE). The viable cells number (colony forming units (CFU)/biofilm) was normalized by dry weight 
(mg) (n = 8). (B) Dose-response effects of BF-CM on the growth of S. mutans biofilm cells (n = 4). (C) 
Representative 3D rendering images of biofilms formed with different dilutions of BF-CM and analyzed via 
multi-photon confocal laser scanning microscopy. S. mutans cells stained with SYTO 9 are depicted in green, 
while EPS labelled with Alexa Fluor 647 is shown in red. Data represent mean ± SD. The quantitative data 
were subjected to analysis of variance (ANOVA) in the Tukey’s HSD test for a multiple comparison. Values are 
significantly different from each other at *P < 0.05 or **P < 0.01.
www.nature.com/scientificreports/
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mimicking biofilm microenvironments. Using a microfluidics fabrication method, defined cell population of 
S. mutans can be directly inoculated and encapsulated within a physical shell surrounding the bacterial culture 
(4 to 5 nanoliter) (Fig. 4A). The nanocultures confine microorganisms within a semipermeable polydimethyl-
siloxane (PDMS) membrane containing growth medium, while allowing transport of small molecules34. Since 
this platform allows chemical fluxes between internal and external environments, it was determined whether S. 
mutans cells grown within the nanoculture respond to bioactive molecules in the BF-CM placed outside of the 
microcapsules.
S. mutans cells were encapsulated in PDMS nanocultures with culture medium, and then seeded in the same 
medium (outside) containing BF-CM or without supplementation (control). Microcolony formation and in situ 
gtfB expression (using PgtfB::gfp strain) within the microcapsules were assessed via optical and confocal micros-
copy. Consistent with the findings using de facto biofilms, the microcolonies appeared visually larger in the nan-
ocultures of S. mutans placed in BF-CM, while the surface area of cell occupying the interior of the capsule was 
significantly higher than control (P < 0.01; Fig. 4B). Future studies shall include quantitative measurements of 
the size (e.g. diameter and volume) of the microcolonies within each of the microcapsule. Furthermore, gtfB 
expression by these bacterial microcolonies was significantly enhanced, showing ~4-fold increase as determined 
via measurement of fluorescence intensity of green fluorescence protein (GFP) (vs. control, P < 0.001) (Fig. 4C). 
Together, these observations suggest that BF-CM harbors small molecules, which are capable of diffusing through 
the PDMS shell and induce the resident bacterial cells to promote microcolony growth with enhanced gtfB 
expression.
Chemical characterization of conditioned medium. Our data suggest that conditioned medium from 
bacterial-fungal biofilm interaction contains specific S. mutans-growth inducing and Gtfs-activating molecules 
Figure 2. Three-dimensional (3D) architecture and quantitative computational analysis of biofilm formed 
in BF-CM. (A) Representative confocal images of S. mutans biofilms grown in BF-CM (1:5vol/vol, CM:UFTYE) 
and without supplementation (control). The bacterial microcolonies are depicted in green (SYTO 9), while 
the EPS-matrix is depicted in red (Alexa Fluor 647). (B) Quantitative analysis of total biovolume (biomass), 
cell/EPS ratio and microcolony volume (size) was performed using COMSTAT. Data represent mean ± SD 
(n = 8). A pairwise comparison between control and BF-CM was conducted using student’s t-test. Values are 
significantly different from each other at *P < 0.05 or **P < 0.01.
www.nature.com/scientificreports/
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that could be critical for enhanced bacterial accumulation observed in previous in vitro and in vivo studies24,25,35. 
Therefore, the composition of carbohydrates and metabolites in BF-CM as well as in the conditioned medium 
from single-species biofilms (B-CM and F-CM) was characterized using colorimetric, high-performance 
anion-exchange chromatography (HPAEC) and 1H nuclear magnetic resonance (1H-NMR) methods (Fig. 5A). 
Since S. mutans efficiently metabolizes sucrose36,37, this carbohydrate was almost completely utilized in the condi-
tioned medium from single-species bacterial (B-CM) or bacterial-fungal (BF-CM) biofilms (Fig. 5B). In contrast, 
most of the carbohydrate remained in the medium from single-species fungal biofilm (F-CM), consistent with C. 
albicans inefficient utilization of sucrose29. Fructose derived from the breakdown of sucrose was detected at high 
concentration in S. mutans conditioned medium. However, there was a significant difference (14.7-fold, P < 0.01) 
between the concentration of fructose contained in B-CM (44 μ M) and BF-CM (3 μ M), indicating active fructose 
metabolism in S. mutans-C. albicans biofilms.
Changes in the metabolite composition and content in the conditioned medium may reflect chemical interac-
tions between S. mutans and C. albicans within biofilms. Hence, the profile of extracellular metabolites (e.g. organic 
acids, alcohols, sugar alcohols, amino acids) in BF-CM, B-CM and F-CM was determined (Figs 5C and S3). 
The results of metabolite composition analyses revealed that lactate was the major metabolite detected in BF-CM 
and B-CM (Figs 5C and S3). Notably, the formate concentration was significantly increased in BF-CM (vs. others, 
P < 0.01).
After initial chemical characterization, further biological evaluation was conducted to determine whether the 
bacterial/microcolony-growth inducing factor could be a functional protein. Since heat treatment, digestion with 
proteinase K, and combination of both did not alter the biological properties of BF-CM but promoted S. mutans 
cell growth compared to non-treated BF-CM (P > 0.05) (Fig. S4), the extracellular microbial factors appeared to 
Figure 3. Dynamics of glucosyltransferases (Gtfs) activity and gtfBC expression profiles in biofilms formed 
in BF-CM. (A) Dose-response effects of BF-CM (diluted in UFTYE, vol/vol) on Gtfs activity. The data were 
subjected to linear regression analysis and analysis of variance (ANOVA) in the Tukey’s HSD test for a multiple 
comparison. Correlation coefficient between increasing amounts of BF-CM and Gtfs activity was r2 = 0.97.  
(B) Temporal effects of BF-CM on Gtfs activity at different stages of biofilm development; early-stage (18–28 h) 
and matured biofilms (28–42 h). (C) Influence of BF-CM (collected at 18 h) on gtfB and gtfC gene expression 
by S. mutans biofilms was analyzed at 18, 22, 28, and 32 h of development. A pairwise comparison between 
control and BF-CM was conducted using student’s t-test. Data represent relative ratio to control (defined as 1); 
mean ± SD (n = 4). Values are significantly different from each other at *P < 0.05, **P < 0.01 or ***P < 0.001.
www.nature.com/scientificreports/
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be non-proteinaceous or non-enzymatic molecules that were small and diffusible. In parallel, BF-CM (treated or 
non-treated, as described above) unexpectedly inhibited C. albicans morphogenesis, blocking the transition from 
yeast to hyphal forms in a dose-dependent manner (Fig. S5). Since farnesol is a small, diffusible quorum-sensing 
(QS) molecule secreted by C. albicans, and is well-known to inhibit the yeast-to-hyphae transition38, additional 
chromatographic analyses were performed to confirm whether farnesol could be detected in BF-CM (Fig. 6). 
BF-CM or F-CM contained detectable amounts of farnesol, with an estimated concentration of 23.3 and 107.6 μ M, 
Figure 4. Microcolony assembly and gtfB expression in situ using a microfluidics-generated nanoculture 
system. (A) Defined cell population of S. mutans (~30 cells per nanoculture) was encapsulated in a 
semipermeable polydimethylsiloxane (PDMS)-based nanoculture (microcapsules). (B) S. mutans cells were 
inoculated in PDMS nanocultures with culture medium (UFTYE) and seeded in the medium (outside) 
containing either BF-CM (1:5 vol/vol, CM:UFTYE) or without supplementation (control). The surface area of  
cell occupying the interior of the capsule was measured by Image J. Data represent mean ± SD (n = 12).  
(C) Microcolony formation and gtfB expression via S. mutans strain expressing GFP under the control of gtfB 
promoter; PgtfB::gfp were determined using optical and confocal microscopy. The GFP fluorescent intensity was 
measured by using Image J. Data represent mean ± SD (n = 20). A pairwise comparison between control and 
BF-CM was conducted using student’s t-test. Values are significantly different from each other at **P < 0.01, 
***P < 0.001.
www.nature.com/scientificreports/
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Figure 5. The composition of carbohydrates and metabolites in the conditioned medium (CM). CM was 
collected and prepared from single-species bacterial (B-CM), fungal (F-CM) or bacterial-fungal (BF-CM) 
biofilms as described in Materials and Methods. (A) HPAEC chromatograms of carbohydrate profile and 1H-
NMR analysis for metabolites (organic acids shown). (B) The concentrations of glucose, fructose and sucrose as 
the main carbohydrates in undiluted CM. (C) The concentrations of formate, fumarate and lactate as the main 
metabolites in undiluted CM. Data represent mean ± SD (n = 3). The data were subjected to analysis of variance 
(ANOVA) in the Tukey’s HSD test for a multiple comparison. The letters (a and b) denote significate differences 
(P < 0.01).
Figure 6. Quantification of farnesol in the conditioned medium (CM). (A) HPLC profile of farnesol was 
obtained from CM extracted with EtOAc. The peak at 30.5 min is of farnesol (red arrows). Conditioned medium 
(CM) was collected and prepared from single-species bacterial (B-CM), fungal (F-CM) or bacterial-fungal (BF-
CM) biofilms at 18 h. (B) Biological concentration of farnesol detected in the CM.
www.nature.com/scientificreports/
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respectively based on HPLC quantification (Fig. 6). As expected, farnesol was undetected in B-CM since 
S. mutans cannot produce and secrete this molecule.
Low concentrations of farnesol enhance the growth of S. mutans biofilm cells and Gtfs activity. 
The identification of farnesol in BF-CM is intriguing because this fungal signaling molecule also exhibits anti-
bacterial activity against S. mutans biofilms at high concentrations (> 1 mM)39. Thus, the biological effects of 
farnesol at a range of concentrations (12.5, 25 and 50 μ M) akin to that found in BF-CM was investigated. To be 
consistent with the experiments using BF-CM, the influences of farnesol on both S. mutans biofilm formation 
and the Gtfs activity were examined. Surprisingly, the results revealed that farnesol at these low concentrations 
actually induced the growth of S. mutans biofilm cells (Fig. 7A), and concomitantly enhanced Gtfs activity in 
a dose-dependent manner (vs. control; Fig. 7B). In contrast, bacterial growth was inhibited by farnesol at high 
concentrations (> 100 μ M; Fig. 7A).
Since the amount of farnesol detected in BF-CM (~25 μ M) promoted the growth of S. mutans and the Gtfs 
activity, further experiments were conducted to confirm whether farnesol can stimulate microcolony develop-
ment and gtfB expression (via PgtfB::gfp). Strikingly, farnesol induced the formation of enlarged microcolonies 
with elevated expression of gtfB (Fig. 7C) in a manner similar to that observed with BF-CM. Together, our data 
suggest that farnesol may be an important molecule mediating this cross-kingdom interaction, with a potential 
role in regulating S. mutans accumulation and microcolony development within cariogenic biofilms.
Discussion
Our findings reveal that extracellular factors derived from the association between S. mutans and C. albicans 
stimulates bacterial growth within the biofilms. Gtfs activity via up-regulation of gtf genes, particularly gtfB, is 
triggered by secreted fungal factors, which in turn enhances microcolony formation by S. mutans. The insoluble 
glucans produced by GtfB can provide bacterial binding sites for S. mutans accumulation, while serving as a struc-
tural scaffold that are essential for microcolony development33,40,41. The microcolonies also facilitate the formation 
Figure 7. Influences of farnesol at levels found in BF-CM on Gtfs activity and S. mutans biofilm formation. 
(A) Influence of farnesol at different concentrations (0–200 μ M) on the S. mutans biofilm cell growth. Data 
represent mean ± SD (n = 4). The data were subjected to analysis of variance (ANOVA) in the Tukey’s HSD 
test for a multiple comparison. §Indicates non-detected. (B) Gtfs activity in S. mutans biofilms grown in the 
presence of farnesol at a range of concentrations (12.5, 25 and 50 μ M). Data represent mean ± SD (n = 6). The 
data were subjected to analysis of variance (ANOVA) in the Tukey’s HSD test for a multiple comparison. (C1) 
Microcolony development and gtfB expression via PgtfB::gfp S. mutans in biofilms formed on sHA surface in the 
presence of farnesol at 25 μ M. Fluorescence images were obtained using confocal laser scanning microscopy. 
(C2) The microcolony size and GFP fluorescence intensity were measured by COMSTAT and Image J. Data 
represent mean ± SD (n = 4). A pairwise comparison between control and farnesol was conducted using 
student’s t-test. Values are significantly different from each other at **P < 0.01 or ***P < 0.001.
www.nature.com/scientificreports/
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of localized acidic microenvironments that promote acid-dissolution of the adjacent tooth enamel10. Interestingly, 
elevated GtfB levels in human saliva42 and increased amounts of insoluble glucans in plaque-biofilms43,44 have 
been associated with caries activity in ECC-affected children. Furthermore, S. mutans defective in gtfB is unable 
to form microcolonies32, to infect teeth or to cause severe carious lesions in rodent caries model45. Thus, it is 
plausible that the presence of C. albicans factors in plaque-biofilms might play an important role in gtfB activation 
in situ, and thereby in the enhanced S. mutans virulence and development of ECC in vivo, which can be further 
elucidated in future longitudinal clinical studies.
Interestingly, the biochemical characterization using a combination of heat treatment and digestion with 
proteinase K, and chromatographic analyses indicate that farnesol may be a key chemical modulator. The role 
of farnesol in mediating C. albicans yeast-to-hyphae transition while exhibiting antibacterial activity has long 
been appreciated38,39. However, S. mutans growth responds non-monotonically to farnesol concentration. At low 
farnesol levels (~25 μ M) found in the conditioned medium from co-cultured biofilms, it enhances bacterial cell 
growth and triggers gtfB expression/activity within biofilms, which correlated with microcolony development by 
S. mutans. In contrast, high concentrations (> 100 μ M) of farnesol inhibited S. mutans growth, consistent with 
previous observations of its antibacterial effects39. However, the presence of S. mutans appeared to reduce farne-
sol production by C. albicans (Fig. 6), which may have contributed to hyphal formation as typically observed in 
co-species biofilms25 (Fig. S2). In addition, farnesol can be incorporated into S. mutans cell membrane due to its 
fatty acid-like structure. We have previously shown that farnesol can be detected in the bacterial cell membrane 
of S. mutans biofilm cells46 as well as planktonic cells following treatment (Fig. S6). These observations suggest a 
well-controlled mechanism to maintain farnesol at levels that promote a symbiotic fungal-bacterial relationship, 
and open intriguing questions as to how cell communication prevent S. mutans and C. albicans from killing or 
inhibiting each other.
Nonetheless, the interactions with S. mutans in co-species biofilms also provide some advantages to C. albi-
cans. The characterization of extracellular sugars and metabolites present in the conditioned media revealed com-
plementary metabolic activity within co-species biofilms. Consistent with the C. albicans inability to efficiently 
metabolize sucrose29, the fungus formed sparse biofilms on sHA surface when grown alone with minimal carbo-
hydrate utilization. However, the presence of S. mutans and its ability to rapidly breakdown sucrose (releasing glu-
cose and fructose) drastically enhanced C. albicans growth within co-species biofilms, accompanied by increased 
utilization of glucose and fructose. Interestingly, enhanced fructose metabolism can also promote C. albicans 
hyphal morphogenesis47,48. In line with the metabolic activity of carbohydrates, lactate (primarily) as well as small 
amounts of formate and fumarate were produced, which, in turn, would favor S. mutans and C. albicans growth 
within cariogenic biofilms, as these microbes are both acidogenic and acid-tolerant49,50. This metabolic cooper-
ation together with modulation of farnesol production provides an effective mechanism that resolves potential 
antagonism, while promoting co-existence and enhancing S. mutans accumulation via Gtf activation.
The findings that S. mutans growth stimulation and Gtf activation through bacterial-fungal interactions are 
achieved within biofilms via secreted molecules also raise new questions. While farnesol at low levels clearly 
induces bacterial growth and gtfB expression simultaneously, the underlying molecular mechanisms are unclear. 
Recently, Peng et al.51 have demonstrated that c-di-AMP intracellular signaling in S. mutans directly regulates gtfB 
expression. Thus, an intriguing concept may arise where by an extracellular QS molecule from a fungus may trig-
ger intracellular signaling of a bacterial pathogen for enhanced expression of a virulence factor (GtfB) associated 
with dental caries7. Whether other S. mutans genes, like sigX (which is induced in the presence of C. albicans)31, 
are affected or not by farnesol in a dose-dependent manner shall be elucidated by assessing the entire S. mutans 
transcriptome response.
At the same time, the complexity of this bacterial-fungal association exists in many different contexts. 
Although this study is focused on the influence of the C. albicans on S. mutans accumulation within bio-
films, the interactions between these microbes are mutually beneficial. How S. mutans and C. albicans inter-
play within co-species biofilms to promote fungal and bacterial growth while modulating yeast-to-hyphae 
transition remains unclear as other factors may be involved. For example, S. mutans-derived mutanobactin A, 
competence-stimulating peptide and trans-2-decenoic acid may act as cross-kingdom signaling molecules that 
regulate C. albicans growth and morphogenesis52–54. Further analysis on the identity and function of other sign-
aling and small diffusible molecules could reveal a complex and multifaceted role. It is intriguing to think that a 
highly regulated interplay between cooperative and competitive interactions occurs to allow a symbiotic relation-
ship between these microbes. Thus, it will be interesting to investigate how these different chemical interactors 
modulate S. mutans and/or C. albicans physiology using our microcapsule-based nanoculture system. This analyt-
ical platform enables the selective diffusion of small molecules while assessing changes in the morphology of the 
microcolonies, which can help elucidate how community behavior can be modified by sensing secreted molecules 
under physical confinement55,56.
In summary, this study provides new insights on the chemical interactions between an opportunistic fungus 
and an oral pathogen, which in part help to explain the in vivo and clinical findings showing enhanced S. mutans 
carriage in the presence of C. albicans in plaque-biofilms associated with ECC. Using a microcapsule-based nano-
culture system, S. mutans cells confined within these chambers responded to chemical interactors (without phys-
ical contact between the microbes) that diffused through the PDMS shell. Further chemical analysis identified 
farnesol as a potential key modulator in this cross-kingdom interaction that, at low concentrations, stimulates 
bacterial growth and gtfB activity, leading to enlarged microcolonies containing densely packed S. mutans cells. 
These observations also suggest new strategies for manipulating this pathogenic bacterial-fungal interaction. For 
example, high concentration of farnesol can be used to inhibit both S. mutans growth and C. albicans transition 
to hyphae, which could lessen the virulence of this cross-kingdom biofilm. In addition, the available evidence 
prompts the possibility of incorporating antifungal therapy in the treatment of ECC.
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Materials and Methods
Microbial strains and growth conditions. Streptococcus mutans UA159 serotype c (an established viru-
lent cariogenic dental pathogen) and Candida albicans SC5314 (a well-characterized fungal strain) were used to 
generate single- or co-species biofilms. A S. mutans strain expressing green fluorescence protein (GFP) under the 
control of the gtfB promoter (PgtfB::gfp) (a gift from Dr. Jose Lemos at College of Dentistry, University of Florida) 
was used for in situ gtfB expression analysis. For inoculum preparation, C. albicans and S. mutans cells were 
grown to mid-exponential phase (optical density at 600 nm (OD600) of 0.65 and 0.5, respectively) in ultrafiltered 
(10-kDa molecular-mass cutoff membrane; Millipore, MA, USA) tryptone-yeast extract broth (UFTYE; 2.5% 
tryptone and 1.5% yeast extract at pH 5.5 and pH 7.0 for C. albicans and S. mutans) with 1% (wt/vol) glucose at 
37 °C and 5% CO2 as described previously17,25.
Single and co-species biofilm model. Biofilms were formed using our established saliva-coated 
hydroxyapatite (sHA) disc model as detailed previously25 (also see Fig. S1). Briefly, sHA discs were vertically sus-
pended in a 24-well plate using a custom-made disc holder32, and inoculated with approximately 2 × 106 (CFU/ml) 
of S. mutans or 2 × 104 (CFU/ml) of C. albicans in 2.8 ml (per well) UFTYE (pH 7.0) containing 1% (wt/vol) sucrose 
at 37 °C under 5% CO2. For co-species biofilms, S. mutans (2 × 106 CFU/ml) and C. albicans (2 × 104 CFU/ml) 
were added to the inoculum (in 2.8 mL (per well) UFTYE (pH 7.0) containing 1% (wt/vol) sucrose); this pro-
portion of the microorganisms is similar to that found in saliva samples from children with ECC11,25. The culture 
medium was changed twice daily at 8 am and 6 pm until the end of the experimental period. The pH of spent 
culture medium was measured daily at each medium change using a standard pH electrode (Thermo Scientific, 
Waltham, MA, USA). Representative single or co-species biofilm 3D architecture is shown in Fig. S2.
Preparation of biofilm-derived conditioned medium. The conditioned medium was collected and 
prepared from each of the biofilms as detailed in Fig. S1. Briefly, the biofilm and the respective surrounding 
culture medium were collected at 6, 18 and 30 h, homogenized via sonication and centrifuged at 5,500 × g for 
10 min at 4 °C. The supernatant was filtered through 0.2 μ m-pore-size membrane filter (ultra-low protein binding, 
surfactant-free cellulose acetate, Nalgene, Rochester, NY, USA), checked for S. mutans and C. albicans contam-
ination via microscopic observation/plating on blood agar and adjusted to pH 7.0. The cell-free conditioned 
medium from single-species bacterial (B-CM) or fungal (F-CM) and bacterial-fungal (BF-CM) biofilms were 
stored at − 20 °C.
Treatments using biofilm-derived conditioned medium. The biological activity of each prepara-
tion of the conditioned medium on the growth of S. mutans biofilm cells was assessed using the sHA biofilm 
model25,32,33. Samples of B-CM, F-CM or BF-CM obtained at different time-points (6, 18 and 30 h) were serially 
diluted with UFTYE (1:2.5, 1:5, 1:10 and 1:20, CM:UFTYE, vol/vol). Thereafter, sucrose was added to each of the 
culture medium preparations at a final concentration of 1% (wt/vol), and the pH adjusted to 7.0. Each sHA disc 
was inoculated with 2 × 106 (CFU/ml) of S. mutans in 2.8 ml (per well) of UFTYE with or without B/F/BF-CM 
supplementation, and the biofilm formed at 37 °C under 5% CO2. Following 42 h of incubation, the biofilms were 
collected and analyzed by means of multi-photon confocal microscope and microbiological analysis for 3D bio-
film architecture and bacterial viability as described previously32,33,57.
Quantitative biofilm analysis. The biofilms formed in each condition were examined using confocal 
microcopy combined with quantitative computational analysis and microbiological assays. Briefly, bacterial 
cells were stained with 2.5 μ M SYTO 9 green-fluorescent nucleic acid stain (485/498 nm; Molecular Probes Inc., 
Eugene, OR, USA), while EPS was labelled with 1 μ M Alexa Fluor 647-dextran conjugate (647/668 nm; Molecular 
Probes Inc.)25,33,57. The imaging was performed using multi-photon Leica SP5 microscope with 20 × LPlan 
(numerical aperture, 1.05) water immersion objective (Leica Microsystems, Buffalo Grove, IL, USA). The excita-
tion wavelength was 780 nm, and the emission wavelength filter for SYTO 9 was a 495/540 OlyMPFC1 filter, while 
the filter for Alexa Fluor 647 was an HQ655/40M-2P filter. The confocal images were analyzed using COMSTAT 
version 1 (available as free download at http://www.imageanalysis.dk), written as scripts for MATLAB software 
(Mathworks, Natick, MA, USA) to calculate the biovolume and size (diameter and height) of microcolonies33. The 
biovolume represents the overall biomass occupied by bacterial cells or EPS within intact biofilms, which provide 
direct measurement of their amounts and ratios across the biofilm depth (from disc surface to fluid phase)33. 
Amira 5.4.1 software (Visage Imaging, San Diego, CA, USA) was used to create 3D renderings to visualize the 
overall architecture of the biofilms.
Furthermore, a separate set of biofilms was used for standard microbiological analysis. Briefly, the biofilm was 
removed from sHA discs and homogenized via water bath sonication followed by probe sonication (30 s pulse at 
an output of 7 W; Branson Sonifier 150, Branson Ultrasonics, Danbury, CT, USA) as described previously25,33; the 
sonication procedure does not kill bacterial cells, while providing optimum dispersal and maximum recoverable 
counts. The homogenized suspension was used to determine the total number of viable cells via plating on blood 
agar using an automated spiral plater (CFU per biofilm)39.
Glucosyltransferases (Gtfs) activity. The Gtfs activity was measured in each of the conditioned medium 
and biofilm culture supernatant. An aliquot (100 μ l) of the medium (adjusted pH 6.5) was mixed with 100 μ l 
of a [14C-glucose]-sucrose substrate (0.2 μ Ci/ml; 200 mM of sucrose, 40 μ M dextran 900, and 0.02% NaN3 in 
buffer consisting of 50 mM KCl, 1 mM CaCl2, and 0.1 mM MgCl2 at pH 6.5) to a final concentration of 100 mM 
(200 μ l final volume). The reaction mixture was incubated at 37 °C with rocking for 4 h. After incubation, the 
radio-labeled glucans were quantified by scintillation counting as described elsewhere58. Gtfs activity was meas-
ured by the incorporation of [14C-glucose] from labeled sucrose into glucans. One unit of Gtfs was defined as the 
amount of enzyme needed to incorporate 1 μ M of glucose into glucan over the reaction period58.
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Assessment of gtf genes expression in biofilms. The dynamics of S. mutans gtf genes expression fol-
lowing the exposure of BF-CM (collected at 18 h) was evaluated at specific-time points (see below) over the course 
of biofilm formation. RNA was extracted and purified using protocols optimized for biofilms formed in vitro59. 
Briefly, disc sets were incubated in RNALater (Applied Biosystems/Ambion, Austin, TX, USA) and the biofilm 
at 18, 22, 28 and 32 h was removed from the sHA discs. The RNAs were purified and DNAse treated on a column 
using the Qiagen RNeasy Micro kit (Qiagen, Valencia, CA, USA). The RNAs (RNA integrity number of 9.5 or 
above; as determined using Bioanalyzer, Agilent Technologies Inc., Santa Clara, CA, USA) were then subjected 
to a second DNaseI treatment with Turbo DNase (Applied Biosystems/Ambion) and purified using the Qiagen 
RNeasy MinElute Cleanup kit (Qiagen). Then, we performed RT-qPCR to measure the expression profiles of gtfB 
and gtfC, which are associated with S. mutans microcolony development33. Briefly, cDNAs were synthesized using 
0.5 μ g of purified RNA and the BioRad iScript cDNA synthesis kit (Bio-Rad Laboratories, Inc., Hercules, CA, 
USA). The resulting cDNAs were amplified with a Bio-Rad CFX96 using previously published specific primers33. 
A standard curve was used to transform the critical threshold cycle (Ct) values to relative numbers of cDNA mol-
ecules. Comparative expression was calculated by normalizing each gene of interest to the 16S rRNA60.
Microfluidics-derived nanoculture system. To examine microcolony growth and in situ gtfB expression 
simultaneously, a gtfB-green fluorescent promoter strain was encapsulated in a recently developed polydimethyl-
siloxane (PDMS)-based nanoculture system34. Briefly, a glass-capillary microfluidic device with hydrodynamic 
flow-focusing and co-flowing geometry was constructed to deliver three fluid phases and generate monodis-
perse water/oil/water (W/O/W) PDMS microemulsion droplets (100–200 μ m in diameter), which were allowed 
to polymerize at 37 °C to form the nanocultures. The three fluid phases were delivered to the microfluidic device 
through polyethylene tubing (Scientific Commodities, Lake Havasu, AZ, USA) attached to syringes (SGE) that 
were driven by positive displacement syringe pumps (Harvard Apparatus, Holliston, MA, USA). The inner aque-
ous phase consisted of defined numbers of S. mutans (~30 cells per nanoculture) suspended in UFTYE (a typical 
low-molecule weight medium) containing 2.5% (wt/vol) sucrose, which was sufficient to reproducibly promote 
microcolony formation without any influences on the bacterial cell growth. The middle phase consisted of 
PDMS (Dow Corning Co., Auburn, MI, USA) with 25% (wt/wt) low viscosity silicone oil (50cSt, Thermo Fisher 
Scientific) and 10% (wt/wt) curing agent. The outside phase comprises 5% (wt/wt) polyvinyl alcohol aqueous 
solution (PVA, 87–89% hydrolyzed, average MW = 13000–23000, Aldrich). Nanoculture formation was moni-
tored with a high-speed camera (Phantom, Vision Research, Wayne, NJ, USA) attached to an inverted microscope 
(Eclipse TE200, Nikon, Tokyo, Japan). The nanocultures were collected in a solution of 0.85% NaCl, UFTYE or 
UFTYE with BF-CM containing 2.5% (wt/vol) sucrose. The S. mutans within the nanocultures were grown at 
37 °C in the presence of 5% CO2 for 24 or 48 h. Images were acquired using confocal laser scanning microscope 
(SP5-FLIM inverted, Leica Microsystems) or fluorescence microscopy (E600 widefield, Nikon). The fluorescence 
intensity of GFP was measured using Image J 1.43.
Data are publicly available through the Gulf of Mexico Research Initiative information & Data Cooperative 
(GRIDC) at http://data.gulfresearchinitiative.org (doi:10.7266/N78G8HQC and doi:10.7266/N7D50K1B).
Chemical characterization of conditioned medium. The amount of sucrose, glucose and fructose were 
quantified using high-performance anion-exchange chromatography (HPAEC) equipped with an electrochemi-
cal detector (ED50; Dionex, Sunnyvale, CA, USA). A 25 μ l portion of aliquot was injected onto a CarboPac PA-1 
pellicular anion-exchange column (Dionex), and isocratically separated by 150 mM NaOH (eluent A) at 1 ml/
min for 12 min. From the HPAEC chromatograms, the intensities of individual peaks were compared to standard 
corresponding to glucose, fructose and sucrose, and the peak areas were calculated to determine the amount of 
respective products. The biofilm-derived metabolites were identified and quantified through 1H nuclear magnetic 
resonance (1H-NMR). Briefly, sample (180 μ l) was added to 20 μ l of D2O containing 2,2-Dimethyl-2-silapentane-
1-sulfonic acid (DSS, final concentration of 0.25 mM, Cambridge Isotope Limited). All spectra were acquired on 
a Bruker Avance III HD NMR spectrometer using a triple resonance inverse (TXI) 3 mm probe (Bruker Biospin, 
Billerica, MA, USA). For high-throughput processing, a Bruker Samplejet was used for sample handling. The 
pulseprogram (noesypr1d) took the shape of the first transient of a 2 dimensional NOESY of the form RD-90-t-
90-tm-90-ACQ (RD = relaxation delay, t = small time delay between pulses, tm = mixing time and ACQ = acqui-
sition). The water signal was saturated using continuous irradiation during RD and tm. The spectra were acquired 
using 76 K data points over a 14 ppm spectral width. Thirty two scans were performed with 1-s interscan (relax-
ation) delay and 0.1-s mixing time. Raw free induction decays from the 1H-NMR acquisition was processed and 
profiled using Chenomx NMR suite 8.0 (Chenomx, Alberta, Canada). 1H-NMR data was evaluated using targeted 
profiling strategy61 that allows quantification of metabolite data in the sample. The significance was determined by 
direct comparison with concentration in the blank solution (original UFTYE medium).
Heat and proteolytic enzyme treatments of the conditioned medium. Each of the conditioned 
medium (B-CM, F-CM and BF-CM) was subjected to treatments with heat or proteolytic enzyme. Briefly, condi-
tioned medium was adjusted from pH 4.2 to pH 7.5 (as optimum pH of proteinase K). Subsequently pH adjusted 
conditioned medium was treated with 100 μ g/ml proteinase K (Sigma-Aldrich) at 37 °C for 2 h and/or heat at 
85 °C for 30 min62. The bioactivity (cell growth and Gtfs activity) of each of the treated-conditioned medium was 
tested as described above.
Farnesol analysis and bioactivity. To determine whether C. albicans-derived farnesol can be detected in 
the conditioned medium, we used established chromatographic analyses38. Farnesol in the conditioned medium 
was extracted with ethyl acetate with pH adjustment (pH 4) or reverse-phase Sep-Pak column (Mega Bond Elut 
fresh cartridge, C18, Agilent Technologies, Inc., Santa Clara, CA, USA) without pH adjustment and detected 
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on thin-layer chromatography (TLC) or high performance liquid chromatography (HPLC). Farnesol (trans, 
trans-farnesol) was purchased from Sigma-Aldrich. Farnesol on TLC plates (Slica gel 60F254, Merck, Darmstadt, 
Germany) was identified through Rf value of standard with detection accomplished with a hand-held UV lamp, 
iodine vapor and vanillin-sulfuric acid63, while farnesol was detected at 196 nm with retention time at 30.5 min 
using a HPLC system equipped with a Shimadzu LC-20 solvent delivery unit and SPD-M20A photodiode array 
detector (Shimadzu, Kyoto, Japan). A mobile phase consisted of acetonitrile and H2O was delivered under gradi-
ent condition on a C18 column (Kinetex C18, 5 μ m, 4.6 internal diameter × 250 mm, Phenomenex, Torrance, CA, 
USA) at a flow rate of 1 ml/min with column temperature set at 40 °C, and injection volume of 20 μ l (adapted from 
Hornby et al.38). The bioactivity of farnesol on S. mutans cell growth, Gtfs activity and microcolony development 
was performed as described in the previous sections.
Statistical analysis. Data represent mean ± standard deviations (SD) from at least 3 distinct experiments. 
The quantitative data were subjected to analysis of variance (ANOVA) in the Tukey’s HSD test for a multiple com-
parison. A pairwise comparison was conducted using student’s t-test.
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